Ticker LaunchReverse merger · Completed · OKUR
OnKure, Inc.
Reverse merger with Reneo Pharmaceuticals, Inc.
OnKure, Inc. merged into Reneo Pharmaceuticals, Inc., a Nasdaq-listed biopharma, in a reverse merger that takes the private company public. The deal was announced on May 13, 2024 and closed on Oct 4, 2024. The combined company trades as OnKure Therapeutics, Inc. (OKUR) on Nasdaq.
OnKure Therapeutics is a clinical-stage biopharmaceutical company advancing a portfolio of precision medicines in oncology. It became Nasdaq-listed through its merger with Reneo Pharmaceuticals.
- Status
- Completed
- Private company
- OnKure, Inc.
- Public company
- Reneo Pharmaceuticals, Inc.
- Public company business before
- Nasdaq-listed biopharma
- Announced
- May 13, 2024
- Closed
- Oct 4, 2024
- Combined company
- OnKure Therapeutics, Inc. (OKUR)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Announcement press release
- Closing 8-K Oct 8, 2024
- All filings on EDGAR CIK 1637715
Other completed reverse mergers
- Lomond Therapeutics, Inc.into Venetian-1 Acquisition Corp. · Nov 1, 2024
- TuHURA Biosciences, Inc.into Kintara Therapeutics, Inc. · Oct 18, 2024
- NAYA Biosciences, Inc.into INVO Bioscience, Inc. · Oct 11, 2024
- Pharmagesic (Holdings) Inc. (Wex Pharmaceuticals)into Virios Therapeutics, Inc. · Oct 7, 2024
- Polomar Specialty Pharmacy, LLCinto Trustfeed Corp. · Sep 30, 2024
- Oruka Therapeutics, Inc.into ARCA biopharma, Inc. · Aug 29, 2024